|
|
Dividend Aristocrats
The blue-chip legacy payers
|
|
ABBVAbbVie just made its 54th straight raise — and the patent cliff is in the rearview
|
AbbVie is the maker of Humira — the autoimmune drug that for years was the best-selling pharmaceutical in the world. They lost the U.S. patent on Humira in 2023, and a lot of people thought the dividend was in real trouble.
Look at the result instead. Two newer drugs, Skyrizi and Rinvoq, did $25.9 billion in combined sales last year. Total revenue rose 8.6% to $61 billion. And in January AbbVie announced a 5.5% raise — taking the quarterly dividend to $1.73 a share, $6.92 a year. That's the 54th straight annual increase. AbbVie inherited the streak from Abbott Labs in the 2013 spinoff and never broke it. They are a Dividend King.
At a 3.3% yield, $10,000 here puts $330 a year in your account — about $82 every February, May, August, and November. The dividend has risen from $0.57 quarterly in 2015 to $1.73 today. That's a 204% bump in ten years.
The risk to know: pharma is always pricing-vulnerable. The Inflation Reduction Act has put Medicare price negotiation onto AbbVie's calendar. And every few quarters they take a big "acquired IPR&D" charge — basically writing off the cost of buying early-stage drug candidates — which makes GAAP earnings look messier than they are. I'd rather see them keep spending on the pipeline. That's what funds the 55th raise next year.
|
|
Yield: 3.3%
|
$10K invested = $330/yr
|
Paid: Quarterly
|
|
|
|
LINLinde sells air — and just raised the dividend 7% for the 33rd straight year
|
I love telling people about Linde because the business model is so straightforward it's almost comic. They take air, separate it into oxygen, nitrogen, argon, and hydrogen, and sell it. To hospitals. To chip fabs. To steel mills. To rocket companies. To welders. To anyone who needs gases that have to be incredibly pure.
The contracts are long. Customers can't easily switch. The pipelines and on-site plants Linde builds belong to Linde. That's the moat — a word that just means a durable competitive advantage that lets you charge what you want without losing customers. And it shows up in the dividend.
In February, Linde raised the quarterly dividend 7% — from $1.50 to $1.60. That's $6.40 a year. The yield is just 1.2%, so $10,000 buys about $120 a year in income today. The reason this matters is the growth rate. Linde's dividend has grown roughly 8.5% a year for the last five years and 7.7% over the last decade. At that pace, your annual check doubles every nine years without you doing anything.
Risk to know — Linde is cyclical. When chip fabs slow, when steel demand softens, when chemical plants idle, Linde's volumes dip. Q1 EPS still grew 10% though, and the payout ratio is around 40%. That's a comfortable spot. Nothing here screams cut.
|
|
Yield: 1.2%
|
$10K invested = $120/yr
|
Paid: Quarterly
|
|
|
|
|
|
Dividend Growth Stars
Fast-rising income builders
|
|
COSTCostco's $1.47 dividend hits accounts Thursday — a 13% raise
|
Costco is the cleanest dividend story I know. They sell groceries and gas and bulk paper towels with razor-thin margins — and they make almost all their actual profit on the $65 and $130 annual membership fees. 81.4 million households pay them just to walk in. Renewal rates run above 90% in the U.S. That recurring fee stream is what funds the dividend.
On April 15, Costco raised the quarterly dividend from $1.30 to $1.47 — a 13% jump. New annualized rate is $5.88. That payment hits this Thursday, May 15. It's the 22nd consecutive annual increase. Plus, in January 2026, they paid a $12-per-share special dividend on top — about $5.3 billion sent to shareholders in a single check.
The headline yield is small — around 0.6% on a roughly $1,000 stock. So $10,000 only buys you about $60 a year in regular income. But here's the thing — Costco's dividend has grown 1,200% since 2004. They throw the special on roughly every 3-4 years on top. If you bought ten years ago, your effective yield on cost is now north of 3% even before counting specials.
Risk to know: COST trades at a sky-high multiple — north of 50 times earnings. If the membership engine ever slows or comp sales soften, the stock can drop fast. Some analysts call Costco overvalued. They've been saying that for a decade and the stock keeps going up. But the valuation isn't free.
|
|
Yield: 0.6%
|
$10K invested = $60/yr
|
Paid: Quarterly
|
|
|
|
AVGOBroadcom's small yield is the income story hiding in the AI trade
|
Broadcom is the second-biggest semiconductor company on earth and one of two names everyone keeps mentioning for AI infrastructure. Their AI revenue alone was $8.4 billion last quarter — up 106% year over year. Total revenue $19.3 billion, up 29%. The stock has been on a tear.
The dividend has been on a quieter tear. In December, AVGO raised the quarterly payout 10% — from $0.59 to $0.65. That's the 15th straight annual increase. Over the last five years the dividend has grown at about 12% a year. The payout ratio is still only around 46% — they have plenty of room to keep raising.
Next ex-dividend date is June 22. Pay date June 30. Headline yield is just 0.62%, so $10,000 only gets you about $62 a year today. But run the compounding. At 12% annual growth, your income doubles every six years. Buy AVGO today and hold for 20 years at that pace, your yield on cost is over 6%.
Risk to know — this is a momentum stock. The stock dropped 4% yesterday after news that the $18 billion OpenAI custom chip deal hit a financing snag. Multiple compression is the AI trade's biggest risk. The dividend is safe at this payout ratio. The stock price is what would hurt if AI capex cools. Different question, different answer.
|
|
Yield: 0.6%
|
$10K invested = $60/yr
|
Paid: Quarterly
|
|
|
|
|
|
The Extra Yield
This week's calendars, screens & answers
|
|
Don't miss these ex-dates: HTGC goes ex-dividend Thursday May 14 — yesterday's pick, $0.47 a share. Costco's $1.47 hits accounts Thursday too, though that ex-date has already passed. Linde's next ex-date is June 4 for the $1.60 payment on June 18.
|
|
I ran a screen this morning: S&P 500 names with at least 10 years of consecutive dividend increases AND a 5-year dividend growth rate above 10%. The top of the list: AVGO, MA, V, MSFT, and LOW. All four of today's picks pass the streak test, but only AVGO clears the 10%-growth bar. That's the screen I'd run if I were building a sleeve for someone in their 40s.
|
|
Someone asked me: "What does 'yield on cost' actually mean? I keep seeing it." Yield on cost is your annual dividend divided by what you originally paid for the stock — not the current price. If you bought AbbVie at $50 a share ten years ago, that $6.92 annual dividend works out to a 13.8% yield on your cost basis. That's the whole point of dividend growth investing. The current yield stays around 3% forever for new buyers, but your personal yield on your old money keeps climbing.
|
|
|
|
The Dispatch
|
|
Today's four: AbbVie at 54 years and a 5.5% raise. Linde at 33 years and a 7% raise. Costco at 22 years and a 13% raise — check hits Thursday. Broadcom at 15 years and 10%. Different yields, same engine. Tomorrow we head somewhere stranger — The Weird Yield is back, plus two more High Yield picks. See you in the morning.
|
|
— Charlie
|
|
|
|